Three New Companies Join TMC Innovation (TMCi)
Three New Companies Join TMC Innovation (TMCi)
Companies will receive customized mentorship to validate and advance their technologies in the largest medical center in the world
HOUSTON, TX (July 19, 2022) – Texas Medical Center Innovation (TMCi) today announced new life science startups will join the TMC Innovation Accelerator for HealthTech. The accelerator provides a unique opportunity for startups harnessing powerful technologies to continue to evolve their products and services while creating lasting relationships with Texas Medical Center (TMC) member institutions, advisors, and investors.
“It is always exciting to introduce a new group of talented entrepreneurs into our community,” said Tom Luby, Director of TMC Innovation. “Each with their own goals, and at their individual stage, we’ll work closely together to help them learn, grow and navigate this rich clinical landscape. We are honored to be the bridge between these innovators and the world’s largest medical city.”
The companies include:
CardMedic (Oxford, UK) – CardMedic believes in making healthcare information accessible for all. So, they built a digital “One Stop Communication Shop” in the form of an extensive library of pre-written scripts to empower staff and patients to communicate across any barrier, including language, deafness, cognitive impairment, or disability.
CardMedic is the next startup to join TMC Innovation from the TMC | United Kingdom BioBridge. The BioBridge partners with countries to help source the best talent and startups across the globe that are ready to enter the US market and bring them to TMC for programs and entry into the market.
“The opportunity to connect with Texas Medical Center member institutions, understand their problem domain, and in what ways that may differ from the United Kingdom is invaluable. We are really excited about learning from the expert team of strategic advisors at the TMCi Accelerator about areas we needed to focus on to grow our company in the United States,” said Rachael Grimaldi, Co-Founder and CEO of CardMedic. in
CareAdvisors (Chicago, Illinois) – CareAdvisors helps hospitals and clinical social workers connect patients to the best resources and quickly enroll them in benefits to address social care needs. The Social Care Automation tool enables hospitals to generate revenue from preventive health programs and helps health plans reduce overutilization by putting the focus on preventive care.
Roboligent (Austin, Texas) – Roboligent designs and manufactures a robot that provides automated physical therapy exercises for patients with upper and lowers limb musculoskeletal issues. Robotic-assisted rehab help promotes recovery while increasing rehab centers’ operational efficiency.
“Introducing a new and innovative product, especially in the medical device field, is a thorough and collaborative effort,” said Bongsu Kim, Founder and CEO of Roboligent. “TMC’s HealthTech Accelerator is the perfect place to make connections with experts and stakeholders to help guide us in reaching our next milestone.”
###
About Texas Medical Center (TMC) — Texas Medical Center (TMC)—the largest medical city in the world—is at the forefront of advancing life sciences. Home to the brightest minds in medicine, TMC nurtures cross-institutional collaboration, creativity, and innovation among its 106,000-plus employees. With a campus of more than 50 million square feet, TMC annually hosts 10 million patients, performs over 180,000 surgeries, conducts over 750,000 ER visits, performs close to 14,000 heart surgeries, and delivers over 25,000 babies. Beyond patient care, TMC is pushing the boundaries of clinical research across its extensive network of partner institutions on a daily basis, pioneering effective health policy solutions to address the complex health care issues of today, and cultivating cutting-edge digital health applications and medical devices.
About Texas Medical Center Innovation (TMCi): TMC Innovation forms, fosters, recruits, and funds healthcare companies worldwide that are writing the future of healthcare. TMCi performs diligence on the companies seeking to progress toward clinical and business milestones in collaboration with the larger TMC and our global network of advisors and embedded corporate partners. We align these resources through our globally recognized programs: Biodesign, Accelerator for Cancer Therapeutics, and Accelerator for Health Tech.